Literature DB >> 25088782

Decreased in vitro anticoagulant potency of Rivaroxaban and Apixaban in plasma from patients with cirrhosis.

Wilma Potze1, Jelle Adelmeijer, Ton Lisman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25088782     DOI： 10.1002/hep.27350

Source DB:  PubMed          Journal:  Hepatology        ISSN： 0270-9139            Impact factor:   17.425


× No keyword cloud information.
  14 in total

1.  Direct oral anticoagulants in rare venous thrombosis.

Authors:  Guido Finazzi; Walter Ageno
Journal:  Intern Emerg Med       Date:  2016-02-13       Impact factor: 3.397

Review 2.  Portal vein thrombosis in cirrhosis: Controversies and latest developments.

Authors:  Damian J Harding; M Thamara P R Perera; Frederick Chen; Simon Olliff; Dhiraj Tripathi
Journal:  World J Gastroenterol       Date:  2015-06-14       Impact factor: 5.742

Review 3.  Algorithms for managing coagulation disorders in liver disease.

Authors:  R Todd Stravitz
Journal:  Hepatol Int       Date:  2018-07-31       Impact factor: 6.047

4.  Portal vein thrombosis in patients with cirrhosis: underdiagnosis and undertreatment?

Authors:  Aaron Liew; James Douketis
Journal:  Intern Emerg Med       Date:  2016-05-23       Impact factor: 3.397

5.  Direct Oral Anticoagulants in Cirrhosis Patients Pose Similar Risks of Bleeding When Compared to Traditional Anticoagulation.

Authors:  N M Intagliata; Z H Henry; H Maitland; N L Shah; C K Argo; P G Northup; S H Caldwell
Journal:  Dig Dis Sci       Date:  2016-01-02       Impact factor: 3.199

6.  Drug Use Evaluation of Direct Oral Anticoagulants (DOACs) in Patients With Advanced Cirrhosis.

Authors:  Lindsey Jarboe; Apaar Dadlani; Sudeepthi Bandikatla; Regan Wade; Ashutosh Barve
Journal:  Cureus       Date:  2022-04-11

7.  Decreased prothrombin conversion and reduced thrombin inactivation explain rebalanced thrombin generation in liver cirrhosis.

Authors:  Romy M W Kremers; Marie-Claire Kleinegris; Marisa Ninivaggi; Bas de Laat; Hugo Ten Cate; Ger H Koek; Rob J Wagenvoord; H Coenraad Hemker
Journal:  PLoS One       Date:  2017-05-04       Impact factor: 3.240

8.  Concepts and Controversies in Haemostasis and Thrombosis Associated with Liver Disease: Proceedings of the 7th International Coagulation in Liver Disease Conference.

Authors:  N M Intagliata; C K Argo; J G Stine; T Lisman; S H Caldwell; F Violi
Journal:  Thromb Haemost       Date:  2018-07-30       Impact factor: 5.249

Review 9.  Portal vein thrombosis in cirrhosis: diagnosis, natural history, and therapeutic challenges.

Authors:  Aikaterini Mantaka; Aikaterini Augoustaki; Elias A Kouroumalis; Dimitrios N Samonakis
Journal:  Ann Gastroenterol       Date:  2018-03-03

10.  In vitro efficacy of pro- and anticoagulant strategies in compensated and acutely ill patients with cirrhosis.

Authors:  Ton Lisman; Simone Kleiss; Vishal C Patel; Caleb Fisher; Jelle Adelmeijer; Sarah Bos; Arjuna Singanayagam; Sidsel H Stoy; Debbie L Shawcross; William Bernal
Journal:  Liver Int       Date:  2018-05-30       Impact factor: 5.828
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.